SECuRE trial update: 92% of pre-chemo participants experience greater than 35% drop in PSA levels across all cohorts. Cohort Expansion Phase commences.
Global Industry Partners Jointly Release Net5.5G Best Practices & Deployment Guide Whitepaper
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance
Litmus Automation, MachineMetrics, and Augury Take the Lead in ABI Research's Data Analytics for OEE: Up-and-Comers Competitive Ranking
Massimo Motor Strengthens Strategic Partnerships at Rural King Vendor Summit, Tractor Supply Company & PetSense ASM and Partner Trade Show
HUAWEI Mobile Services Signals Strong Commitment to Transforming the Future of Tourism at MWC 2025
Agora Launches Conversational AI Engine for Seamless Voice AI Experiences
Neuchips Partners with Vecow and GSH to Accelerate Proprietary Data Processing with Offline Gen AI
